510(k) K252357
K252357 is an FDA 510(k) premarket notification submitted by Abbott Ireland for the device "Glucose2". The FDA issued a decision of Substantially Equivalent on October 24, 2025. The device falls under product code CFR (Hexokinase, Glucose), a Class II device regulated under 21 CFR 862.1345. Abbott Ireland has at least 1 other 510(k) clearance on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 24, 2025
- Date Received
- July 29, 2025
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Hexokinase, Glucose
- Device Class
- Class II
- Regulation Number
- 862.1345
- Review Panel
- CH
- Submission Type